Sentiment · FY2026 Q1
What companies say about each other on earnings calls — extracted verbatim from public transcripts. Mentions from the newest quarter are a Pro feature.
“Over the next few months, we expect to transition 11 communities to Pegasus Senior Living and eight communities to CL Senior Living under highly aligned management contracts.”
Healthpeak is awarding CL Senior Living management of eight senior housing communities under aligned contracts, a positive read-through on CL's operating pipeline.
“Over the next few months, we expect to transition 11 communities to Pegasus Senior Living and eight communities to CL Senior Living under highly aligned management contracts.”
Healthpeak is awarding Pegasus Senior Living management of 11 senior housing communities under aligned contracts, a positive read-through on Pegasus's operating pipeline.
“I appreciate that the step down in retention and outpatient was largely due to the CommonSpirit leases no longer being included.”
CommonSpirit, a health-system tenant, had leases roll off Healthpeak's outpatient portfolio, driving a step-down in reported retention.
“Like the agreements with Pfizer and AstraZeneca, and that's been a big part of the change in sentiment.”
Healthpeak cites AstraZeneca's agreement with the administration as part of the improved biopharma policy backdrop lifting life science leasing sentiment.
“Like the agreements with Pfizer and AstraZeneca, and that's been a big part of the change in sentiment.”
Healthpeak points to Pfizer's agreement with the administration as a positive that has improved biopharma sector sentiment and life science leasing demand.
“we've had one tenant get acquired by Eli Lilly. That's now public.”
Eli Lilly acquired one of Healthpeak's life science tenants during the call, cited as evidence of accelerating biopharma M&A that supports lab real estate demand.
“grow our portfolio by $5 billion in a strategic merger with Physicians Realty Trust.”
Healthpeak credits its 2023 merger with Physicians Realty Trust for establishing its leading outpatient medical platform, framing it as a major value creator.
“we've been deploying very recently some of the commercially available artificial intelligence applications throughout our organization, including ChatGPT and Copilot”
Healthpeak is deploying Microsoft's Copilot alongside ChatGPT internally as part of its AI roadmap for operational efficiency.
“The M&A activity has been strong. You've seen some great prints there from Merck and Sanofi.”
Healthpeak's CFO cites recent Merck M&A activity as a positive leading indicator of improving biopharma capital markets, which supports demand for Healthpeak's life-science tenant base.
“supported by our relationship with Northside Hospital, a fast-growing and highly successful regional health systems. And new developments are anchored by Northside, outpatient services and physicians and/or 78% pre-leased before commencement of construction, with a strong leasing pipeline behind that.”
Healthpeak's newly closed $150 million Atlanta outpatient development is anchored by Northside Hospital and already 78% pre-leased, reflecting Northside's continued regional growth and expansion needs.
“we've selected Hines to join as the development partner to advance the residential component of the project. Hines brings a depth of expertise in place making, multifamily construction and mixed use development which will allow us to commence this project once we are fully entitled late next year.”
Healthpeak selected Hines as development partner for the residential component of its West Cambridge master-plan project, giving Hines a role in advancing a large mixed-use life-science campus.
“It highlighted our ability to execute and to exceed expectations, for example, with merger synergies and the common spirit renewal.”
Healthpeak cites an opportunistic early lease renewal with hospital operator CommonSpirit Health as a key example of outperformance following the Physicians Realty merger.
| Analyst | Firm | Questions (Challenge)Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| Farrell Granath | Bank of America | 12 (0%) |
| Vikram Malhotra | Mizuho Securities | 11 (9%) |
| Austin Wurschmidt | KeyBanc Capital Markets | 11 (0%) |
| Omotayo Okusanya | Deutsche Bank | 10 (10%) |
| Ron Kamdem | Morgan Stanley | 9 (0%) |
| Mike Carroll | RBC Capital Markets | 9 (0%) |
| Rich Anderson | Wedbush Securities | 9 (11%) |
| Wes Golladay | Robert W. Baird | 9 (0%) |
| Juan Sanabria | BMO Capital Markets | 8 (13%) |
| Nick Yulico | Scotiabank | 8 (0%) |
| Firm | Analysts | Questions (Challenge)Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| Bank of America | 1 | 12 (0%) |
| BMO Capital Markets | 2 | 11 (9%) |
| Citigroup | 2 | 11 (0%) |
| Wells Fargo | 2 |
| 11 (0%) |
| Green Street | 2 | 11 (9%) |
| KeyBanc Capital Markets | 1 | 11 (0%) |
| Mizuho Securities | 1 | 11 (9%) |
| Robert W. Baird | 2 | 11 (0%) |
DOC delivered 4% full-year same-store NOI growth with FFO as adjusted of $0.47 per share in Q4 and $1.84 for the full year, in line with guidance midpoint despite the historic lab environment. Senior housing delivered 16.7% Q4 same-store growth while the Gateway campus acquisition in South San Francisco and Janus Living senior housing IPO were announced. FY2026 FFO guidance was introduced at $1.70-1.74, reflecting the lab occupancy lag at 77% with early signs of inflection.
Demand | Capital Allocation | Capex Investment | M&A | Competitive Dynamics | Guidance Reliability | Credit | Revenue Growth | |
|---|---|---|---|---|---|---|---|---|
| 2024Q4 | 10 | 8 | 10 | 4 | 4 | 3 | 3 | |
| 2025Q1 | 11 | 3 | 11 | 2 | 5 | 3 | ||
| 2025Q2 | 12 | 4 | 2 | 2 | 3 | 1 | 6 | 1 |
| 2025Q3 | 12 | 11 | 2 | 2 | 1 | 1 | 1 | |
| 2025Q4 | 11 | 5 | 3 | 6 | 1 | 5 | 1 | |
| 2026Q1 | 6 | 4 | 1 | 3 | 3 | 3 | 2 |
| '24Q4 | '25Q1 | '25Q2 | '25Q3 | '25Q4 | '26Q1 | |
|---|---|---|---|---|---|---|
| Demand | 10 | 11 | 12 | 12 | 11 | 6 |
| Capital Allocation | 8 | 3 | 4 | 11 | 5 | 4 |
| Capex Investment | 10 | 11 | 2 | 2 | 3 | 1 |
| M&A | 4 | 2 | 2 | 6 | 3 | |
| Competitive Dynamics | 4 | 2 | 3 | 1 | 1 | 3 |
| Guidance Reliability | 3 | 1 | 1 | 5 | 3 | |
| Credit | 5 | 6 | 1 | 1 | ||
| Revenue Growth | 3 | 3 | 1 | 2 |
| Company | Score | Trend | Rev YoY |
|---|---|---|---|
DOC Healthpeak Properties | 6 | +7.1% | |
| VTR Ventas | 8 | +22.0% | |
| WELL Welltower | 8 | +40.3% |